Oaktree Acquisition Corp. III Life Sciences
For the period ended Jun 30, 2026. Filed Aug 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 12, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
Factors that could cause our actual results to differ materially from those in this Report include the risk factors described in our Annual Report on Form
10-K
for the year ended December 31, 2025 filed with the SEC on March 26, 2026. As of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form
10-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.